.
Pharmaceutical Information
Study Course Description
Course Description Statuss:Approved
Course Description Version:7.00
Study Course Accepted:25.08.2023 13:05:41
Study Course Information | |||||||||
Course Code: | ZFTK_049 | LQF level: | Level 7 | ||||||
Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
Branch of Science: | Basic Sciences of Medicine, including Pharmacy; Social Pharmacy | Target Audience: | Pharmacy | ||||||
Study Course Supervisor | |||||||||
Course Supervisor: | Elvis Pumpurs | ||||||||
Study Course Implementer | |||||||||
Structural Unit: | Department of Applied Pharmacy | ||||||||
The Head of Structural Unit: | |||||||||
Contacts: | Riga, 16 Dzirciema Street, zftkrsu[pnkts]lv, +371 67061547 | ||||||||
Study Course Planning | |||||||||
Full-Time - Semester No.1 | |||||||||
Lectures (count) | 0 | Lecture Length (academic hours) | 0 | Total Contact Hours of Lectures | 0 | ||||
Classes (count) | 8 | Class Length (academic hours) | 4 | Total Contact Hours of Classes | 32 | ||||
Total Contact Hours | 32 | ||||||||
Part-Time - Semester No.1 | |||||||||
Lectures (count) | 4 | Lecture Length (academic hours) | 4 | Total Contact Hours of Lectures | 16 | ||||
Classes (count) | 4 | Class Length (academic hours) | 4 | Total Contact Hours of Classes | 16 | ||||
Total Contact Hours | 32 | ||||||||
Study course description | |||||||||
Preliminary Knowledge: | Pharmaceutical chemistry, pharmacognosy, compounding and industrial dosage form technology, pharmaceutical pharmacology. | ||||||||
Objective: | 1. Learn about different sources of pharmaceutical information. 2. Differentiate between commercial and non-commercial sources of information. 3. Develop skills in information retrieval, learn to assess quality of the information. 4. Develop written and oral presentation skills. 5. Acquire the methodology and structure of scientific research. | ||||||||
Topic Layout (Full-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Research methodology. Qualitative research studies and their role in health care. | Classes | 1.00 | auditorium | |||||
2 | Development and presentation of scientific work. Forms of plagiarism. | Classes | 1.00 | auditorium | |||||
3 | Pharmaceutical information, characteristics. Evidence based information resources. | Classes | 1.00 | auditorium | |||||
4 | Work with non-commercial pharmaceutical information sources. Use of European Medicines Agency and State Agency of Medicines of the Republic of Latvia databases as sources of information. Medicinal product registration procedures. | Classes | 1.00 | auditorium | |||||
5 | International medication classification systems. WHO ATC/DDD classification system, its structure, characteristics and use. | Classes | 1.00 | auditorium | |||||
6 | The concept of drug analogues. Names of medicines. | Classes | 1.00 | auditorium | |||||
7 | Information about medicines intended for society. Advertising of medicines to the public. | Classes | 1.00 | auditorium | |||||
8 | Information on medicines intended for health care professionals. Advertising of medicines for health care professionals. Intellectual property. Concept of access to medicines. | Classes | 1.00 | auditorium | |||||
Topic Layout (Part-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Research methodology. Qualitative research studies and their role in health care. | Lectures | 1.00 | auditorium | |||||
2 | Development and presentation of scientific work. Forms of plagiarism. | Classes | 1.00 | auditorium | |||||
3 | Pharmaceutical information, characteristics. Evidence based information resources. | Lectures | 1.00 | auditorium | |||||
4 | Work with non-commercial pharmaceutical information sources. Use of European Medicines Agency and State Agency of Medicines of the Republic of Latvia databases as sources of information. Medicinal product registration procedures. | Classes | 1.00 | auditorium | |||||
5 | International medication classification systems. WHO ATC/DDD classification system, its structure, characteristics and use. | Lectures | 1.00 | auditorium | |||||
6 | The concept of drug analogues. Names of medicines. | Classes | 1.00 | auditorium | |||||
7 | Information about medicines intended for society. Advertising of medicines to the public. | Classes | 1.00 | auditorium | |||||
8 | Information on medicines intended for health care professionals. Advertising of medicines for health care professionals. Intellectual property. Concept of access to medicines. | Lectures | 1.00 | auditorium | |||||
Assessment | |||||||||
Unaided Work: | Reading assignments, analysis of research publications, case studies, semester paper. In order to evaluate the quality of the study course as a whole, the student must fill out the study course evaluation questionnaire on the Student Portal. | ||||||||
Assessment Criteria: | Individual and practical assignments, presentation, group semester project, individual and group tests, written exam. The total grade of the course will consist of the grade obtained during the semester. 30% of the final grade consists of individual and group tests, 20% of the group work done during the semester, and 50% of the final grade consists of the exam. | ||||||||
Final Examination (Full-Time): | Exam (Written) | ||||||||
Final Examination (Part-Time): | Exam (Written) | ||||||||
Learning Outcomes | |||||||||
Knowledge: | Upon completion of this course, students will know: 1. different types of pharmaceutical information sources; 2. the general principles of evidence-based medicine; 3. how to use key evidence-based pharmaceutical information storages; 4. quality criteria for pharmaceutical information sources; 5. different types of pharmaceutical promotion; 6. the key principles of promoting rational use of medicines; 7. the research methodology and principles of research development and how to formalize study. | ||||||||
Skills: | Upon completion of this course, students will: 1. distinguish between commercial and non-commercial pharmaceutical information sources; 2. be able to assess validity and reliability of various pharmaceutical information sources; 3. be able to use evidence-based knowledge to provide the patient with timely, correct and rational pharmacotherapy; 4. be able to develop tailored information retrieval strategy and find necessary information; 5. be able to formulate the aim, hypothesis, tasks of scientific research. Will be able to choose and describe the research methods used. Will be able to develop and design research according to RSU requirements. | ||||||||
Competencies: | Upon completion of this course, students will be able to: 1. use pharmaceutical literature, evidence-based databases and other non-commercial sources of information on medicines, independently critically appraise the content of the information obtained and the adequacy of information sources before its use; 2. present pharmaceutical information tailored for various audiences; 3. make ethical decisions regarding pharmaceutical promotion. | ||||||||
Bibliography | |||||||||
No. | Reference | ||||||||
Required Reading | |||||||||
1 | ATC index with DDD’s. – Oslo: WHO Collaborating Centre for Drug Statistics Methodology. | ||||||||
2 | Ethical criteria for Medicinal Drug Promotion. – Geneva: WHO, 1988. (akceptējams izdevums) | ||||||||
3 | Farmācijas likums: Latvijas Republikas likums. 10.04.1997. Latvijas Vēstnesis. 103, 24.04.1997. (akceptējams izdevums) | ||||||||
4 | International Nonproprietary Names (INN) for Pharmaceutical Substances: Lists of Recommended and Proposed INNs. – Geneve: WHO. | ||||||||
5 | Kokreina apvienības veidotie sistemātiskie pārskati | ||||||||
6 | Ministru Kabinets. 17.05.2011. Zāļu reklamēšanas kārtība un kārtība, kādā zāļu ražotājs ir tiesīgs nodot ārstiem bezmaksas zāļu paraugus: MK noteikumi Nr. 378. Latvijas Vēstnesis. 78, 20.05.2011. (akceptējams izdevums) | ||||||||
7 | Nacionālā veselības dienesta interneta vietne | ||||||||
8 | Pasaules medicīnas citējamo žurnālu datubāze PubMed | ||||||||
9 | Reklāmas likums: Latvijas Republikas likums. 20.12.1999. Latvijas Vēstnesis. 7, 10.01.2000. (akceptējams izdevums) | ||||||||
10 | The National Institute for Health and Care Excellence Guidance | ||||||||
11 | WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2019. Oslo, Norway, 2018. | ||||||||
12 | WHO. Model List of Essential Medicines. 2019. | ||||||||
13 | Zāļu valsts aģentūras interneta vietne | ||||||||
14 | Ārvalstu studentiem/For international students | ||||||||
15 | ATC index with DDD’s. – Oslo: WHO Collaborating Centre for Drug Statistics Methodology. | ||||||||
16 | Ethical criteria for Medicinal Drug Promotion. – Geneva: WHO, 1988. (akceptējams izdevums) | ||||||||
17 | International Nonproprietary Names (INN) for Pharmaceutical Substances: Lists of Recommended and Proposed INNs. – Geneve: WHO. | ||||||||
18 | WHO. Model List of Essential Medicines. 2019. | ||||||||
Additional Reading | |||||||||
1 | Malone, P.M., Kier, K.L., Stanovich J.E., Malone, M.J. (2014). Drug information: a guide for pharmacists. 5th edition. McGraw Hill. |